All You Need to Know About Stevanato (STVN) Rating Upgrade to BuyZacks Investment Research • 09/11/23
Stevanato Group to Report Second Quarter 2023 Financial Results on July 28, 2023Business Wire • 07/14/23
Strength Seen in Stevanato (STVN): Can Its 5.0% Jump Turn into More Strength?Zacks Investment Research • 06/19/23
Stevanato Group Presents Vertiva™, a Versatile On-Body Delivery System Platform for a Wide Range of Injectable Therapies and for Large Delivery Volumes (up to 10mL)Business Wire • 06/12/23
As Covid Wanes, Maker Of Glass Vials, Other Medical Products Misses EstimatesInvestors Business Daily • 05/04/23
Stevanato Group S.p.A. (STVN) Hit a 52 Week High, Can the Run Continue?Zacks Investment Research • 04/18/23
Stevanato Group to Report First Quarter 2023 Financial Results on May 4, 2023Business Wire • 04/17/23
Stevanato Group S.p.A. (STVN) Hits Fresh High: Is There Still Room to Run?Zacks Investment Research • 03/30/23
Stevanato Group Collaborates with Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to MarketBusiness Wire • 03/21/23
Stevanato Group Collaborates with Recipharm to Develop and Manufacture Pre-fillable Syringes for Use in a New Soft Mist Inhaler for the Inhalation of Sensitive Biological ProductsBusiness Wire • 03/16/23
Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor ForumBusiness Wire • 03/14/23
Stevanato Group Secures €130 Million ESG-Linked Financing From BNL BNP Paribas and Cassa Depositi e Prestiti to Support Sustainable Global GrowthBusiness Wire • 03/08/23
Surging Earnings Estimates Signal Upside for Stevanato (STVN) StockZacks Investment Research • 03/07/23
Stevanato Group Reports Fourth Quarter and Fiscal Year 2022 Financial ResultsBusiness Wire • 03/02/23
Stevanato Group to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 2, 2023Business Wire • 02/16/23